Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission

Autor: Denise Cerqueira Paranaguá‐Vezozzo, Débora Raquel Benedita Terrabuio, Gleicy Luz Reinoso‐Pereira, Renata Moutinho, Suzane Kioko Ono, Veronica Walwyn Salas, Joao Italo Dias França, Venâncio Avancini Ferreira Alves, Eduardo Luiz Rachid Cançado, Flair José Carrilho
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: JGH Open, Vol 7, Iss 4, Pp 272-277 (2023)
Druh dokumentu: article
ISSN: 2397-9070
DOI: 10.1002/jgh3.12865
Popis: Abstract Background and Aim The aim was to analyze the concordance of liver stiffness measurement (LSM) either by transient elastography (TE) or ARFI with liver biopsy in autoimmune hepatitis (AIH) patients with biochemical remission and to identify those with histological remission. Liver biopsy is still the golden standard for AIH diagnosis. However, it is an invasive procedure and these patients, most of the time, require many biopsies, so it would be valuable to search for noninvasive method that could select all these patients and keep under observation. Methods Thirty‐three patients with AIH were submitted for liver biopsy to evaluate histological remission after at least 18 months of normal aminotransferases. The efficiency of LSM and fibrosis stages was tested by a receiver operating characteristic curve analysis (AUROC). Results One patient (3%) was F0, 6 (18.2%) were F1, 8 (24.2%) were F2, 10 (30.3%) were F3, and 8 (24.2%) were F4, according to METAVIR. Thirteen of thirty‐three (39.4%) patients did not achieve histological remission. AUROC for F4 stage was 0.83 (IC: 0.76–0.99) for TE and 0.78 (IC: 0.65–0.95) for ARFI. Optimal LSM cutoff values were 12.3 kPa (Se = 87.5%, Sp = 88%) for TE and 1.65 m/s (Se = 87.5%, Sp = 76%) for ARFI. The tests were unable to differentiate patients with histological activity from those in histological remission (P
Databáze: Directory of Open Access Journals